0000063754-20-000202.txt : 20201202 0000063754-20-000202.hdr.sgml : 20201202 20201202153506 ACCESSION NUMBER: 0000063754-20-000202 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20201202 DATE AS OF CHANGE: 20201202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rimmer Nneka Louise CENTRAL INDEX KEY: 0001638423 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14920 FILM NUMBER: 201363630 MAIL ADDRESS: STREET 1: 18 LOVETON CIRCLE CITY: SPARKS STATE: MD ZIP: 21152 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MCCORMICK & CO INC CENTRAL INDEX KEY: 0000063754 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090] IRS NUMBER: 520408290 STATE OF INCORPORATION: MD FISCAL YEAR END: 1130 BUSINESS ADDRESS: STREET 1: 24 SCHILLING ROAD STREET 2: SUITE 1 CITY: HUNT VALLEY STATE: MD ZIP: 21031 BUSINESS PHONE: 4107717301 MAIL ADDRESS: STREET 1: 24 SCHILLING ROAD STREET 2: SUITE 1 CITY: HUNT VALLEY STATE: MD ZIP: 21031 FORMER COMPANY: FORMER CONFORMED NAME: MCCORMICK & CO DATE OF NAME CHANGE: 19660620 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-11-30 0000063754 MCCORMICK & CO INC MKC 0001638423 Rimmer Nneka Louise MCCORMICK & COMPANY, INCORPORATED 24 SCHILLING ROAD, SUITE 1 HUNT VALLEY MD 21031 0 1 0 0 President - Global Flavors and Extracts Common Stock - Voting 18398 D Options - Right to Buy 93.49 2020-11-30 4 A 0 85152 0 A Coimmon Stock - Voting 85152 85152 D Amounts reported herein reflect the Issuer's 2 for 1 stock split of its common stock and common stock non-voting, effective November 30, 2020. The option grant vests after the third anniversary date and is only exercisable if certain stock price performance requirements are met. The performance requirements are an increase in the common stock non-voting price of 60% for 1/3 of the options, an increase in the common stock non-voting price of 80% for 1/3 of the options, and an increase in the common stock non-voting price of 100% for 1/3 of the options, in each case within five years of the grant date. Both the vesting date and perfomance requirements must be met for the portion of the grant to become exercisable. Jason E. Wynn, Attorney-in-fact 2020-12-02